ISEC Healthcare Ltd. (40T.SI)
- Previous Close
0.3450 - Open
0.3450 - Bid 0.3350 x --
- Ask 0.3500 x --
- Day's Range
0.3450 - 0.3450 - 52 Week Range
0.2500 - 0.4500 - Volume
100 - Avg. Volume
6,985 - Market Cap (intraday)
198.442M - Beta (5Y Monthly) -0.15
- PE Ratio (TTM)
17.25 - EPS (TTM)
0.0200 - Earnings Date Aug 11, 2025 - Aug 15, 2025
- Forward Dividend & Yield 0.01 (4.06%)
- Ex-Dividend Date Apr 28, 2025
- 1y Target Est
--
ISEC Healthcare Ltd., an investment holding company, provides medical care, consultancy, treatment, and surgery services in the field of ophthalmology in Singapore, Malaysia, and Myanmar. It operates in two segments, Specialised Health Services and General Health Services. The company offers various services, including cataract and intraocular lens implant, refractive surgery, vitreous and retinal diseases, adult strabismus and paediatric ophthalmology, glaucoma diagnostics and therapeutics, medical retinal diseases, uveitis, optometry and orthoptics, oculoplastics, facial cosmetics, and aesthetic surgery, as well as cornea, external eye disease, and anterior segment. It also provides general medical and procedural treatment services. In addition, the company operates eye care centers. The company was founded in 2007 and is headquartered in Singapore. ISEC Healthcare Ltd. operates as a subsidiary of Aier Eye International (Singapore) Pte. Ltd.
www.isechealthcare.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 40T.SI
View MorePerformance Overview: 40T.SI
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is STI Index (^STI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 40T.SI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 40T.SI
View MoreValuation Measures
Market Cap
198.44M
Enterprise Value
193.47M
Trailing P/E
15.57
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.64
Price/Book (mrq)
2.14
Enterprise Value/Revenue
2.57
Enterprise Value/EBITDA
8.72
Financial Highlights
Profitability and Income Statement
Profit Margin
16.96%
Return on Assets (ttm)
9.81%
Return on Equity (ttm)
14.25%
Revenue (ttm)
75.14M
Net Income Avi to Common (ttm)
12.74M
Diluted EPS (ttm)
0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
17.27M
Total Debt/Equity (mrq)
13.02%
Levered Free Cash Flow (ttm)
4.19M